Best of NOTES™

This session will present current information regardng the safety and efficacy of NOTES™ and evolving developments in the performance of NOTES™ procedures.

Objectives:

At the conclusion of this session, participants will be able to:

• List the new findings regarding the safety and effectiveness of NOTES™.
• Review new technical advances in NOTES™.
• Discuss the evolving human trials of NOTES™.

Introduction

• NOSCAR™ – What is it and Why Does it Matter?
  David Rattner, M.D.
• NOTES™ Access Routes and Access Closure
  Richard Rothstein, M.D.
• Infectious Issues and NOTES™: Laboratory Studies to Date, Sterile Conduits – Necessary or Not?
  Jeffrey Marks, M.D.

Economics of Device Development (videos unavailable)

• The NOTES™ Toolkit – What We Need
  Bernard Dallemagne, M.D.
• From Idea to Prototype
  Paul Swain, M.D.

Platform Development

• Retraction with Magnets
  Daniel Scott, M.D.
• Review of Current Multitasking Platforms
  Christopher Thompson, M.D.
• Robotics and NOTES™
  Santiago Horgan, M.D.
• IRB Requirements for Human Procedures
  Lee Swanstrom, M.D.
• Human NOTES™ Procedures to Date International View
  Ricardo Zorron, M.D.
• Human NOTES™ in the USA
  W. Scott Melvin, M.D.
• Training and Credentialing for NOTES™
  Brian Dunkin, M.D.
• NOTES™: Reimbursement Issues
  Steven Schwaitzberg, M.D.

First Debate

• NOTES™ Will Not Have a Significant Impact in MIS
  C. Daniel Smith, M.D.
• NOTES™ is the Next Phase in MIS
  Michael Marohn, M.D.
• The Future of NOTES™ is in the 3rd World
  GV Rao, M.D.

Second Debate: Visualization and Turf for NOTES™

• Laparoscopic/Surgical Approach?
  Jeffrey Hazey, M.D.
• Gastroenterologists Will Do NOTES™
  Anthony Kalloo, M.D.

Discussion

SAGES acknowledges generous educational grants in support of this course from Covidien, Karl Storz Endoscopy-America, Olympus Surgical America, and Stryker Endoscopy.